An uncontrolled, open-label trial in nine patients with probable Alzheimers disease and related dementias, who were also taking acetylcholinesterase inhibitors, reported that oral supplementation with 600 mg/day of lipoic acid appeared to stabilize cognitive function over a one-year period (101)
For example, an OR over 1 means higher risk, and under 1 means lower risk
Overall appearance looks more refreshed and youthful, reflecting reduced oxidative stress rather than just cosmetic change
But, the insufficiency of the transsulfuration pathway is also responsible of HHcy
Internet based clinical trial matching tool
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma